The SCICONX Journal of Vaccine and Immunology (JVI) aims to serve as a rigorous, forward‑looking scholarly platform for the publication of high‑quality research that advances the understanding of immune mechanisms and supports innovation in vaccine science. The journal is dedicated to promoting scientifically sound, ethically conducted, and methodologically robust studies that contribute to the prevention, control, and management of diseases through immune‑based strategies.

This Journal seeks to bridge fundamental immunological research with translational and clinical applications by encouraging interdisciplinary contributions from immunologists, vaccinologists, clinicians, public health experts, and biomedical scientists. The journal prioritizes work that enhances knowledge of immune responses, informs vaccine design and evaluation, and supports evidence‑based immunization practices across diverse populations.

Through timely publication and global accessibility, the journal aims to facilitate meaningful scientific exchange, support informed decision‑making in healthcare & public health, and contribute to long‑term improvements in global immune protection.

Scope

The SCICONX Journal of Vaccine and Immunology publishes original and impactful research covering a broad spectrum of topics related to immunology and vaccine science. The journal welcomes contributions that explore molecular, cellular, systemic, and population‑level aspects of immune function and vaccine performance.

Areas of interest include, but are not limited to:

Vaccinology and Vaccine Development

• Design, formulation, and optimization of vaccines
• Preclinical and clinical evaluation of vaccine candidates
• Novel antigen discovery and validation
• Adjuvants and immune‑enhancing strategies
• Vaccine delivery systems and administration routes

Immunological Mechanisms

• Innate and adaptive immune responses to vaccination
• Immune memory, tolerance, and durability of protection
• Cellular and humoral immunity dynamics
• Immunogenetics and host immune variability
• Immune correlates and biomarkers of protection

Emerging and Innovative Vaccine Platforms

• mRNA, DNA, viral vector, and recombinant vaccines
• Nanotechnology‑based and biomaterial‑assisted vaccines
• Personalized and precision vaccine approaches
• Combination vaccines and heterologous immunization strategies

Clinical and Translational Immunology

• Vaccine efficacy, effectiveness, and safety studies
• Immunotherapy and immune‑modulating interventions
• Vaccine responses in special populations
• Translational studies linking laboratory findings to clinical outcomes

Infectious and Non‑Infectious Disease Applications

• Vaccines against bacterial, viral, parasitic, and fungal diseases
• Vaccines for emerging and re‑emerging pathogens
• Cancer vaccines and therapeutic immunization
• Vaccines targeting chronic and non‑communicable conditions

Public Health, Policy, and Implementation Science

• Immunization programs and population‑level impact
• Vaccine acceptance, hesitancy, and communication research
• Surveillance, pharmacovigilance, and adverse event monitoring
• Health systems research related to vaccine deployment

Interdisciplinary and Computational Approaches

• Systems immunology and immune modeling
• Bioinformatics, genomics, and proteomics in vaccine research
• Artificial intelligence and data‑driven approaches to immunology
• Integrative and cross‑disciplinary vaccine research

Types of Studies Encouraged

The journal encourages the submission of diverse study designs, including experimental, observational, clinical, and computational research. High‑quality negative or confirmatory findings that contribute to scientific transparency and reproducibility are also welcome.

Commitment to Scientific Quality

All manuscripts submitted to the SCICONX Journal of Vaccine and Immunology are expected to demonstrate originality, clarity, and relevance to the journal’s aims. Submissions should be supported by appropriate methodology, ethical approval where applicable, and transparent reporting of data and results.

By maintaining a comprehensive and inclusive scope, the journal aims to support innovation across the full continuum of vaccine and immunology research while upholding the highest standards of academic publishing.